Records containing: Sjogren's Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity
-
CLINICAL_TRIALS study results posted · 2026-10-28An Evaluation of Tangible Boost Replenishing System for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Versus Host Disease
-
CLINICAL_TRIALS study record update · 2026-09-14A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity
-
CLINICAL_TRIALS study record update · 2026-04-20Characterization of Diseases With Salivary Gland Involvement
-
CLINICAL_TRIALS study record update · 2026-04-20The Pathogenesis and Natural History of Sjogren's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-06Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Disease Phase IIa Open-Label Clinical Trial and Associated Mechanistic Studies
-
CLINICAL_TRIALS study record update · 2026-04-02Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-23A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren's Disease
-
CLINICAL_TRIALS study record update · 2026-03-23Effects of Aerobic Exercise on Fatigue in Women With Primary Sjögren's Syndrome: Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-11A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients
-
CLINICAL_TRIALS study record update · 2026-03-06Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-03-04An Exploratory Clinical Study on the Safety and Efficacy of YTS109 Cell in Subjects With Relapsing/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-03-02Penn Sjögren's International Clinical Collaborative Alliance (SICCA) Follow-up Study
-
CLINICAL_TRIALS study record update · 2026-02-13Rheumatology Patient Registry and Biorepository
-
CLINICAL_TRIALS study record update · 2026-02-03Clinical Study on the Safety, Efficacy, and Pharmacokinetics of CAR-T Cell Injection Targeting CD19 in the Treatment of Patients With Active Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity
-
CLINICAL_TRIALS study record update · 2026-01-08Transforming Health Habits: Evaluating an Online Wellness Program for Individuals With Rheumatological Conditions
-
CLINICAL_TRIALS study record update · 2026-01-08Maternal Autoimmune Disease Research Alliance (MADRA) Registry
-
CLINICAL_TRIALS study record update · 2025-12-30In Vitro Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2025-12-24Impact of Generative Artificial Intelligence on Diagnosing Rheumatoid Arthritis Complications
-
CLINICAL_TRIALS study record update · 2025-12-18Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome; a Phase Ib-IIa Placebo-controlled Clinical Trial and Associated Mechanistic Studies
-
CLINICAL_TRIALS study record update · 2025-12-04A Randomized Placebo-controlled, Double Blind Pilot Crossover Trial of Levocarnitine for the Treatment of Keratoconjunctivitis Sicca in Sjogren's Syndrome
-
CLINICAL_TRIALS study record update · 2025-12-03Efficacy, Immunogenicity and Safety of Recombinant Vaccine Against Herpes Zoster (RZV or SHINGRIX®) in Patients With Autoimmune Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2025-12-01Application of [68Ga]Ga-FAPI-04 PET/CT in the Assessment of Inflammatory Activity in Sjögren's Syndrome
-
CLINICAL_TRIALS study record update · 2025-11-17Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity